Current guidelines recommend transdermal delivery of testosterone for post-menopausal women seeking treatment for hypoactive sexual desire disorder. Medherant’s TEPI patch has been developed to fill ...
As consumer attention around transdermal wellness patches grows in 2026, interest has also expanded around ingredient visibility, product variety, and policy transparency across the category. This ...
Transdermal estradiol patches show similar PSA response to LHRHa when combined with ARPIs in metastatic prostate cancer. The STAMPEDE trial indicates tE2 patches offer a favorable safety profile, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results